Ken Griffin Medi Wound Ltd. Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	BUY	$3.77 - $6.05 $62,838 - $100,841	16,668 New	16,668 $90,000
Q3 2020 Nov 16, 2020	SELL	$3.09 - $4.14 $38,516 - $51,605	-12,465 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.47 - $2.97 $18,323 - $37,021	12,465 New	12,465 $37,000
Q1 2020 May 15, 2020	SELL	$1.57 - $3.1 $28,137 - $55,558	-17,922 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.72 - $3.15 $48,747 - $56,454	17,922 New	17,922 $55,000
Q1 2018 May 11, 2018	SELL	$3.9 - $5.5 $59,907 - $84,485	-15,361 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$4.25 - $5.2 $65,284 - $79,877	15,361	15,361 $68,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $683M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.